Assessment of potential digoxin-rabeprazole interaction after formulary conversion of proton-pump inhibitors.
Le
Grace H
GH
Veterans Affairs San Diego Healthcare System (VASDHS), 3350 La Jolla Village Drive, San Diego, CA 92161, USA.
Schaefer
Monica G
MG
Plowman
Brian K
BK
Morreale
Anthony P
AP
Delattre
Melissa
M
Okino
Lisa
L
Felicio
Leda
L
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000368:Aged; D001562:Benzimidazoles / Q000494:pharmacology* / Q000627:therapeutic use; D004077:Digoxin / Q000097:blood* / Q000627:therapeutic use; D004347:Drug Interactions; D005572:Formularies, Hospital as Topic; D006801:Humans; D064747:Lansoprazole; D008297:Male; D009853:Omeprazole / Q000031:analogs & derivatives / Q000627:therapeutic use; D011446:Prospective Studies; D054328:Proton Pump Inhibitors; D064750:Rabeprazole
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D001562:Benzimidazoles; D054328:Proton Pump Inhibitors; D064747:Lansoprazole; D064750:Rabeprazole; D004077:Digoxin; D009853:Omeprazole